High sensitivity pyrogen testing in water and dialysis solutions

Journal of Immunological Methods

Volumn 336, Issue 1, 2008, Pages 64-70

  Daneshian, Mardas ^a   Wendel, Albrecht ^a   Hartung, Thomas ^a,b   von Aulock, Sonja ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

Dialysis fluids; Interleukin 1 beta ; Lipopolysaccharide; Pyrogen testing; Whole blood test

Indexed keywords

DIALYSIS FLUID; ENDOTOXIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PYROGEN; WATER;

ARTICLE; BLOOD; DIAGNOSTIC TEST; ESCHERICHIA COLI; IN VITRO PYROGEN TEST; MICROBIAL CONTAMINATION; MICROORGANISM DETECTION; PRIORITY JOURNAL;

DIALYSIS SOLUTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICROSPHERES; PYROGENS; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

LIMULUS AMOEBOCYTE;

EID: 43849103680     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.03.013     Document Type: Article

References (22)

1. Daneshian M., Guenther A., Wendel A., Hartung T., and von Aulock S. In vitro pyrogen test for toxic or immunomodulatory drugs. J. Immunol. Methods 313 (2006) 169
2. Darveau R.P., Pham T.T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., Howald W.N., Way S.S., and Hajjar A.M. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 72 (2004) 5041
3. Dehus O., Hartung T., and Hermann C. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J. Endotoxin Res. 12 (2006) 171
4. Dinarello C.A. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10 (2004) 201
5. Fennrich S., Fischer M., Hartung T., Lexa P., Montag-Lessing T., Sonntag H.G., Weigandt M., and Wendel A. Detection of endotoxins and other pyrogens using human whole blood. Dev. Biol. Stand. 101 (1999) 131
6. Hartung T., and Wendel A. Detection of pyrogens using human whole blood. In Vitro Toxicol. 9 (1996) 353
7. Hoffmann S., Peterbauer A., Schindler S., Fennrich S., Poole S., Mistry Y., Montag-Lessing M., et al. International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 298 (2005) 191
8. Karanicolas S., Oreopoulos D.G., Izatt S., Shimizu A., Manning R.F., Sepp H., de Veber G.A., and Darby T. Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysis. N. Engl. J. Med. 296 (1977) 1336
9. Kindinger I., Daneshian M., Baur H., Gabrio T., Hofmann A., Fennrich S., von Aulock S., and Hartung T. A new method to measure air-borne pyrogens based on human whole blood cytokine response. J. Immunol. Methods 298 (2005) 143
10. Ledebo I. Ultrapure dialysis fluid-direct and indirect benefits in dialysis therapy. Blood Purif. 22 Suppl. 2 (2004) 20
11. Mangram A.J., Archibald L.K., Hupert M., Tokars J.I., Silver L.C., Brennan P., Arduino M., Peterson S., Parks S., Raymond A., McCullough M., Jones M., Wasserstein A., Kobrin S., and Jarvis W.R. Outbreak of sterile peritonitis among continuous cycling peritoneal dialysis patients. Kidney Int. 54 (1998) 1367
12. Martis L., Patel M., Giertych J., Mongoven J., Taminne M., Perrier M.A., Mendoza O., Goud N., Costigan A., Denjoy N., Verger C., and Owen Jr. W.F. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 365 (2005) 588
13. Mazzotti F., Beuttler J., Zeller R., Fink U., Schindler S., Wendel A., Hartung T., and von Aulock S. In vitro pyrogen test-a new test method for solid medical devices. J. Biomed. Mater. Res. A 80 (2007) 276
14. Morath S., Geyer A., and Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193 (2001) 393
15. Poole S., and Mussett M.V. The International Standard for Endotoxin: evaluation in an international collaborative study. J. Biol. Stand. 17 (1989) 161
16. Schindler S., Spreitzer I., Loschner B., Hoffmann S., Hennes K., Halder M., Brugger P., Frey E., Hartung T., and Montag T. International validation of pyrogen tests based on cryopreserved human primary blood cells. J. Immunol. Methods 316 (2006) 42
17. Staubach K.H., Boehme M., Zimmermann M., and Otto V. A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber. Transfus. Apheresis Sci. 29 (2003) 93
18. Ullrich H., Jakob W., Frohlich D., Rothe G., Prasser C., Drobnik W., Taeger K., Meier-Hellmann A., Reinhart K., Zimmermann M., and Schmitz G. A new endotoxin adsorber: first clinical application. Ther. Apher. 5 (2001) 326
19. Walev I., Klein J., Husmann M., Valeva A., Strauch S., Wirtz H., Weichel O., and Bhakdi S. Potassium regulates IL-1 beta processing via calcium-independent phospholipase A2. J. Immunol. 164 (2000) 5120
20. Ward R.A. Ultrapure dialysate. Semin. Dial. 17 (2004) 489
21. Zimmermann, M. (2000) In vitro Untersuchungen zum Adsorptionsverhalten eines Endotoxinadsorbers auf der Basis von immobilisiertem Humanalbumin. In. Ph. D. thesis, University of Saarbrücken.
22. Zimmermann M., Busch K., Kuhn S., and Zeppezauer M. Endotoxin adsorbent based on immobilized human serum albumin. Clin. Chem. Lab. Med. 37 (1999) 373